Massimo Radaelli, PhD, MBA

Chair, Cytovia International

Dr. Massimo Radaelli, Ph.D. founded Noventia Pharma in 2009 and serves as its Chairman, President, and Chief Executive Officer. Dr. Radaelli served as the President and Chief Executive Officer of Dompé International SA., the international pharmaceutical company of the Dompe Group.

​

He joined Dompe in 1996 as Director of Corporate Business Development and was responsible for the initiation of Dompe’s global strategy in its Swiss subsidiary and for its strategic planning, licensing, alliances, and new-product opportunities in Europe. He held various sales and marketing positions at the Dupont-Merck Pharmaceutical Company, Hoffman-La Roche Ltd., and the Menarini Group.

​

He serves as the Executive Chairman of Bioakos Pharma. He serves as a Director of Dompe Farmaceutici SpA, Dompe SpA and Philogen SpA, a privately held Italian biopharmaceutical company.

​

He serves as a Director of IDRI, a non-profit organization focused on neglected diseases.

​

He served as an Independent Director of Ariad Pharmaceuticals Inc. from October 2008 until July 2016, and as a Director of NovaBay Pharmaceuticals, Inc. from January 2014 until May 2016. Dr. Radaelli received a University Degree in Pharmaceutical Sciences and a Ph.D. in Clinical Pharmacology from the University of Milan and an Executive Master of Business from Bocconi University of Milan.